Category Archives: Cardiology

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

Review of the TCT 2015 data

October 19, 2015

Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford | Leave a comment

Review of the TAVR data from the 2015 ACC

May 7, 2015- Interviewed by Steven E. Greer, MD

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

The Sapien 3 TAVR valve

September 9, 2015- By Steven E. Greer, MD We interviewed William O’Neill, MD, a principal investigator for the Edwards Lifesciences Sapien valve trials,

Posted in Cardiology | Leave a comment

Can a “calculator” really tell doctors who should be on Lipitor?

November 13, 2013- By Steven E. Greer, MD The AHA released the long-awaited new guidelines that recommend which patients should be

Posted in Cardiology, Uncategorized | Leave a comment

The newly approved Edwards Lifesciences Sapien 3 aortic valve

July 5, 2015- Interviewed by Steven E. Greer, MD We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, UCLA | Leave a comment

Astronaut and Senator John Glenn suffers stroke after TAVR

May 14, 2015- By Steven E. Greer, MD Stroke is the bane of TAVR. In the Edwards Lifesciences Sapien valve, stroke rates exceed 10%.

Posted in - Medical Devices, - Opinion, Cardiology | Leave a comment

The PCSK9 LDL drugs do not cut heart risk in half

March 18, 2015- Op-Ed by Steven E. Greer, MD The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data

Posted in - Biotech, - Opinion, Cardiac surgery, Cardiology, Primary care medicine | Leave a comment

The deadly risks of TAVR being downplayed to patients by hospitals

January 18, 2015- By Steven E. Greer, MD On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to

Posted in - Medical Devices, - Opinion, Cardiac surgery, Cardiology, FDA | Leave a comment

Occluding the left atrial appendage to prevent stroke in A-fib

May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

Drug-coated balloons to treat fem-pop disease

April 27, 2014– Interviewed by Steven E. Greer, MD At the Charing Cross symposium in London, Medtronic reported results of the IN-PACT trial

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

How many stent cases does it take to bill Medicare for $18 Million?

April 9, 2014- By Steven E. Greer, MD The release of data by Medicare showing what each doctor earns from billing CMS is making news for

Posted in Cardiac surgery, Cardiology, CMS, Congress | Leave a comment

Catheter approaches for mitral replacement

March 23, 2014- interviewed by Steven E. Greer, MD With catheter based methods for replacing the aorta valve not being adopted as expected, the

Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford | Leave a comment

The subcutaneous ICD

The concept of applying high voltage to shock a heart out of

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

The ACC seems to support dangerous energy drinks

March 6, 2014- By Steven E. Greer, MD The Maryland State Assembly will begin debate on a bill to regulate “energy drinks”, such as those

Posted in - Policy, Cardiology | Leave a comment

The FDA discusses Brilinta

February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal

Posted in - Pharma, Cardiology, FDA | Leave a comment

CBS allows TV doctor to make egregious claims about statins

Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading

Posted in - Pharma, Cardiology, Cedars Sinai | Leave a comment

The finances of TAVI: do prices have to come down?

November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS | Leave a comment

TAVI: Comparing CoreValve to Sapien

November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

The more we know, the more unnecessary President Bush’s stent seems

October 16, 2013 By Steven E. Greer, MD A recent short article in an obscure Washington, DC wonky journal triggered national media

Posted in Cardiac surgery, Cardiology | Leave a comment